Business Description
Radiopharm Theranostics Ltd
Share Class Description:
RADX: ADRDescription
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.39 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -3.55 | |||||
| Beneish M-Score | -4.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | |||||
| Quick Ratio | 1.3 | |||||
| Cash Ratio | 1.06 | |||||
| Days Sales Outstanding | 554.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -55.54 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -12247.83 | |||||
| Net Margin % | -16036.45 | |||||
| FCF Margin % | -7697.99 | |||||
| ROE % | -148.69 | |||||
| ROA % | -68.41 | |||||
| ROIC % | -60.05 | |||||
| ROC (Joel Greenblatt) % | -73383.42 | |||||
| ROCE % | -85 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 23 | |||||
| PB Ratio | 0.38 | |||||
| EV-to-EBIT | -0.66 | |||||
| EV-to-EBITDA | -0.71 | |||||
| EV-to-Revenue | 104.59 | |||||
| EV-to-FCF | -1.36 | |||||
| Earnings Yield (Greenblatt) % | -151.52 | |||||
| FCF Yield % | -45.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RADX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Radiopharm Theranostics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.199 | ||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 3.86 - 50.82 | ||
| Shares Outstanding (Mil) | 2,200.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Radiopharm Theranostics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Radiopharm Theranostics Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Radiopharm Theranostics Ltd Frequently Asked Questions
What is Radiopharm Theranostics Ltd(RADX)'s stock price today?
The current price of RADX is $4.30. The 52 week high of RADX is $50.82 and 52 week low is $3.86.
When is next earnings date of Radiopharm Theranostics Ltd(RADX)?
The next earnings date of Radiopharm Theranostics Ltd(RADX) is .
Does Radiopharm Theranostics Ltd(RADX) pay dividends? If so, how much?
Radiopharm Theranostics Ltd(RADX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers